LGALS1 and glioblastoma: To this end, we used an in-house protein tissue microarray including a cohort of 110 GBM patient biopsies (61 primary and 49 recurrent GBM) and 12 biopsies from normal tissues (four each from brain, liver, and tonsil) and performed immunohistochemistry using an anti-galectin-1 antibody.